Merck cuts 51 jobs as it closes Inspire site

On August 31, Merck will officially close the Raleigh, NC headquarters of Inspire Pharmaceuticals, an eye drug specialist that the company bought in April for $430 million. At the time of the purchase, Inspire had 60 employees; Merck said 51 positions would be eliminated when the facility closes later this summer. Report

Suggested Articles

J&J studied the drug in midphase obesity clinical trials, but Merck sees it as a potential treatment for nonalcoholic steatohepatitis.

The Big Pharma paid $134 million to enter into the two partnerships, but then dropped the projects after Voyager completed research activities. 

Combining a vaccine targeting HER2D16 with a PD-1 inhibitor improved tumor regression in mice with HER2-positive breast cancer.